PharmaPhorum 7 February 2018
- Discussion of the learning from the Cancer Vanguard-Merck-IQVIA-UMOTIF joint working initiative from a recent IQVIA/pharmaphorum roundtable discussion, “Improving outcomes through industry partnership – the Cancer Vanguard learnings”.
- The Christie collaboration looked at how to use NHS resources more efficiently, improving quality, reducing unwarranted variation in care and establishing a better understanding of the experience of cancer patients during treatment. By collecting relevant data, it has helped to shape an evidence-based and patient-centric approach to service redesign and resource optimisation. One novel aspect of the study involved asking patients to record their symptoms – such as mobility, and energy levels – using uMotif’s smartphone-based app.
